ATS Educational Products
2015
| C9 |
INTERSTITIAL LUNG DISEASE: THE LATEST ON DIAGNOSIS AND MANAGEMENT |
| D7 |
ATS Journal articles on LAM
American Journal of Respiratory and Critical Care Medicine
Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management
(2016)
Read Abstract
Genetic Heterogeneity of Circulating Cells from Patients with Lymphangioleiomyomatosis with and without Lung Transplantation
Vol. 191, No. 7 (2015), pp. 854-856.
Read Abstract
Tuberous Sclerosis Complex 2 Loss of Heterozygosity in Patients with Lung Disease and Cancer
Vol. 191, No. 3 (2015), pp. 352-355.
Read Abstract
Chronic Sirolimus Therapy for Lymphangioleiomyomatosis
Vol. 190, No. 12 (2014), pp. 1332-1333.
Read Abstract
Sustained Effects of Sirolimus on Lung Function and Cystic Lung Lesions in Lymphangioleiomyomatosis
Vol. 190, No. 11 (2014), pp. 1273-1282.
Read Abstract
Lymphangioma Presenting as Hemoptysis in Pregnancy
Vol. 188, No. 3 (2013), pp. 397-398
Read Abstract
To Be or Not To Be a Neoplasm: What Is Lymphangioleiomyomatosis? Are We Calling It What It Really Is?
Vol. 188, No. 3 (2013), pp. 397-398
Read Abstract
Exonic Mutations of TSC2/TSC1 Are Common but Not Seen in All Sporadic Pulmonary Lymphangioleiomyomatosis
Vol. 187, No. 6 (2013), pp. 663-665
Read Abstract
American Journal of Respiratory Cell and Molecular Biology
Tuberous Sclerosis Complex 2 Loss Increases Lysophosphatidylcholine Synthesis in Lymphangioleiomyomatosis
Vol. 53, No. 1 (2015), pp. 33-41.
Read Abstract
Surfactant Dysfunction and Lung Inflammation in the Female Mouse Model of Lymphangioleiomyomatosis
Vol. 53, No. 1 (2015), pp. 96-104.
Read Abstract
Rapamycin-Resistant Poly (ADP-Ribose) Polymerase-1 Overexpression Is a Potential Therapeutic Target in Lymphangioleiomyomatosis
Vol. 51, No. 6 (2014), pp. 738-749.
Read Abstract
Reply: Hormonally Targeted Therapy for Women with Lymphangioleiomyomatosis
Vol. 50, No. 3 (2014), pp. 665.
Read Abstract
Is There Still a Role for Hormonal Blockade in Lymphangioleiomyomatosis?
Vol. 50, No. 3 (2014), pp. 665.
Read Abstract
The Antimalarial Drug Artesunate Inhibits Primary Human Cultured Airway Smooth Muscle Cell Proliferation
Vol. 50, No. 2 (2014), pp. 451-458.
Read Abstract
Annals of ATS
Efficacy and Safety of Long-Term Sirolimus Therapy for Asian Patients with Lymphangioleiomyomatosis
(2016)
Read Abstract
Imaging Biomarkers in Lymphangioleiomyomatosis Clinical Trials. A Wolf in Sheep’s Clothing?
(2016)
Read Abstract
A Novel Quantitative Computed Tomographic Analysis Suggests How Sirolimus Stabilizes Progressive Air-trapping in Lymphangioleiomyomatosis
(2016)
Read Abstract
Regional Sparing in an Oligemic Lung Segment Supports Hematogenous Spread as a Pathogenic Mechanism in Lymphangioleiomyomatosis
Vol. 12, No. 8 (2015), pp. 1247-1248.
Read Abstract
Kaposiform Lymphangiomatosis, a Newly Characterized Vascular Anomaly Presenting with Hemoptysis in an Adult Woman
Vol. 11, No. 1 (2014), pp. 92-95.
Read Abstract
ATS Statements, Guidelines and Reports
ATS Statements, Guidelines and Reports are printed in the American Journal of Respiratory and Critical Care Medicine. These documents are also available in PDF format. You may download one copy of any ATS document; there is no charge for this service. Some examples below:
